Brief: Algorae Pharmaceuticals Partners With Peter Maccallum Cancer Centre For Second AI-Driven Drug Synergy Screening Program
30/03/2026 02:41
March 30 (Reuters) - Algorae Pharmaceuticals Ltd 1AI.AX: CO PARTNERS WITH PETER MACCALLUM CANCER CENTRE FOR SECOND AI-DRIVEN DRUG SYNERGY SCREENING PROGRAM Further company coverage: 1AI.AX ((Reuters.Briefs@thomsonreuters.com;))
Recent news on Algorae Pharmaceuticals
See all newsAlgorae Pharmaceuticals rises on Australian distribution deal with India's Umedica
Brief: Algorae Pharmaceuticals Executes Licence & Supply Agreement With Umedica
Australia's Algorae Pharmaceuticals gains on Peter MacCallum Cancer Centre partnership
Brief: Algorae Pharmaceuticals Partners With Peter Maccallum Cancer Centre
Brief: Algorae Pharmaceuticals Named Launch Partner In Sovereign Ai Infrastructure Initiative